UCN2 and cardiac arrest: In another preclinical cardiac arrest model, the intravenous (i.v.)administration of Ucn2 (10 μg/kg) upon the onset of resuscitation ameliorated left ventricular systolic and diastolic functions and cardiac output, while it decreased cardiomyocyte apoptosis assessed by TUNEL assay.